Novartis Q2 Adj. EPS $2.41 Beats $2.13 Estimate, Sales $14.408B Beat $14.042B Estimate
Novartis (NYSE:NVS) reported quarterly earnings of $2.41 per share which beat the analyst consensus estimate of $2.13 by 13.15 percent. This is a 0.41 percent decrease over earnings of $2.42 per share from the same